July 9, 2004

Exhibit 10.1(b)

July 9, 2004

Xxxx Laboratories, Inc.

Xxx Xxxxxx Xxxx

X.X. Xxx 0000

Xxxxxx, Xxx Xxxx 00000

Attention: President

Re: Amendment No. 1 to License and Supply Agreement

Dear Sir:

This letter is to confirm our understanding concerning an amendment to be made with respect to the License and Supply Agreement dated as of July 7, 2004 (the “Agreement”), between Cephalon, Inc. (“Cephalon”) and Xxxx Laboratories, Inc. (“Xxxx”).  All terms not otherwise defined herein are used as defined in the Agreement.

The Agreement is hereby amended as follows:

1. Section 1.21 of the Agreement, the “Xxxx-Cephalon License Effective Date,” is hereby deleted in its entirety and replaced with the following:

“1.21  ‘Xxxx-Cephalon License Effective Date’ means the Consent Agreement Effective Date.”

2. Except as amended hereby, the Agreement remains in full force and effect.

If the foregoing accurately reflects your understanding as to these matters, please indicate your agreement in the space provided below, and return one fully-executed original to me.

			Very truly yours,
			CEPHALON, INC.
			By:	/s/ Xxxx Xxxxx
			Name:		Xxxx Xxxxx, FRCP
			Title:		Sr. V.P., Clinical Research &
					Regulatory Affairs
Acknowledged and agreed to by:
XXXX LABORATORIES, INC.
By:	/s/ Xxxxxxxxx X. Xxxxxxx
Name: Xxxxxxxxx X. Xxxxxxx
Title: Sr. VP and General Counsel

A-1